Fatty acid binding protein deletion suppresses inflammatory pain through endocannabinoid/N-acylethanolamine-dependent mechanisms

Molecular Pain

Volumn 11, Issue 1, 2015, Pages

  Kaczocha, Martin ^a   Glaser, Sherrye T ^b   Maher, Thomas ^c   Clavin, Brendan ^c   Hamilton, John ^c   O'Rourke, Joseph ^c   Rebecchi, Mario ^a   Puopolo, Michelino ^a   Owada, Yuji ^d   Thanos, Panayotis K ^c  

^a STONY BROOK UNIVERSITY   (United States)

^b KINGSBOROUGH COMMUNITY COLLEGE   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anandamide; Endocannabinoid; FABP; Fatty acid binding protein; Pain

Indexed keywords

ACETIC ACID; ACYLGLYCEROL LIPASE; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CAPSAZEPINE; CARRAGEENAN; CYCLOOXYGENASE 2; ENDOCANNABINOID; ETHANOLAMINE; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 5; FATTY ACID BINDING PROTEIN 7; FORMALDEHYDE; N ACYLETHANOLAMINE; N OLEOYLETHANOLAMINE; PALMIDROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 1 ANTAGONIST; ETHANOLAMINE DERIVATIVE; FABP5 PROTEIN, MOUSE; FABP7 PROTEIN, MOUSE; N-ACYLETHANOLAMINES; NERVE PROTEIN; TUMOR PROTEIN;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; BINDING AFFINITY; CATABOLISM; CONTROLLED STUDY; EVOKED RESPONSE; GENOTYPE; HARGREAVES TEST; HOME-CAGE ACTIVITY TEST; HYDROLYSIS; INFLAMMATORY PAIN; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ROTAROD TEST; UPREGULATION; VISCERAL PAIN; WESTERN BLOTTING; WRITHING TEST; ANIMAL; C57BL MOUSE; COMPLICATION; DEFICIENCY; INFLAMMATION; KNOCKOUT MOUSE; MALE; METABOLISM; MOTOR ACTIVITY; NOCICEPTION; PAIN; PATHOPHYSIOLOGY;

ANIMALS; ENDOCANNABINOIDS; ETHANOLAMINES; FATTY ACID-BINDING PROTEIN 7; FATTY ACID-BINDING PROTEINS; INFLAMMATION; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; NOCICEPTION; PAIN;

EID: 84940186368     PISSN: 17448069     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/s12990-015-0056-8     Document Type: Article

References (23)

1. De Leon M, Welcher AA, Nahin RH, Liu Y, Ruda MA, Shooter EM, et al. Fatty acid binding protein is induced in neurons of the dorsal root ganglia after peripheral nerve injury. J Neurosci Res. 1996;44(3):283-92. doi: 10.1002/(SICI)1097-4547(19960501)44:3<283:AID-JNR9>3.0.CO;2-C .
2. Yamamoto T, Yamamoto A, Watanabe M, Matsuo T, Yamazaki N, Kataoka M, et al. Classification of FABP isoforms and tissues based on quantitative evaluation of transcript levels of these isoforms in various rat tissues. Biotechnol Lett. 2009;31(11):1695-701. doi: 10.1007/s10529-009-0065-7 .
3. Furuhashi M, Hotamisligil GS. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov. 2008;7(6):489-503. doi: 10.1038/nrd2589 .
4. Kaczocha M, Glaser ST, Deutsch DG. Identification of intracellular carriers for the endocannabinoid anandamide. Proc Natl Acad Sci USA. 2009;106(15):6375-80. doi: 10.1073/pnas.0901515106 .
5. Kaczocha M, Vivieca S, Sun J, Glaser ST, Deutsch DG. Fatty acid-binding proteins transport N-acylethanolamines to nuclear receptors and are targets of endocannabinoid transport inhibitors. J Biol Chem. 2012;287(5):3415-24. doi: 10.1074/jbc.M111.304907 .
6. Kaczocha M, Rebecchi MJ, Ralph BP, Teng YH, Berger WT, Galbavy W, et al. Inhibition of fatty acid binding proteins elevates brain anandamide levels and produces analgesia. PLoS One. 2014;9(4):e94200. doi: 10.1371/journal.pone.0094200 .
7. Sanson B, Wang T, Sun J, Wang L, Kaczocha M, Ojima I, et al. Crystallographic study of FABP5 as an intracellular endocannabinoid transporter. Acta Crystallogr D Biol Crystallogr. 2014;70(Pt 2):290-8. doi: 10.1107/S1399004713026795 .
8. Lichtman AH, Shelton CC, Advani T, Cravatt BF. Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia. Pain. 2004;109(3):319-27. doi: 10.1016/j.pain.2004.01.022 .
9. Schlosburg JE, Kinsey SG, Lichtman AH. Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation. AAPS J. 2009;11(1):39-44. doi: 10.1208/s12248-008-9075-y .
10. Lo Verme J, Fu J, Astarita G, La Rana G, Russo R, Calignano A, et al. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol Pharmacol. 2005;67(1):15-9. doi: 10.1124/mol.104.006353 .
11. D'Agostino G, La Rana G, Russo R, Sasso O, Iacono A, Esposito E, et al. Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor-alpha agonist, modulates carrageenan-induced paw edema in mice. J Pharmacol Exp Ther. 2007;322(3):1137-43. doi: 10.1124/jpet.107.123265 .
12. Elmes MW, Kaczocha M, Berger WT, Leung K, Ralph BP, Wang L, et al. Fatty acid-binding proteins (FABPs) are intracellular carriers for delta9-tetrahydrocannabinol (THC) and cannabidiol (CBD). J Biol Chem. 2015;290(14):8711-21. doi: 10.1074/jbc.M114.618447 .
13. Yu S, Levi L, Casadesus G, Kunos G, Noy N. Fatty acid-binding protein 5 (FABP5) regulates cognitive function both by decreasing anandamide levels and by activating the nuclear receptor peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) in the brain. J Biol Chem. 2014;289(18):12748-58. doi: 10.1074/jbc.M114.559062 .
14. Berger WT, Ralph BP, Kaczocha M, Sun J, Balius TE, Rizzo RC, et al. Targeting fatty acid binding protein (FABP) anandamide transporters-a novel strategy for development of anti-inflammatory and anti-nociceptive drugs. PLoS One. 2012;7(12):e50968. doi: 10.1371/journal.pone.0050968 .
15. Matsumata M, Sakayori N, Maekawa M, Owada Y, Yoshikawa T, Osumi N. The effects of fabp7 and fabp5 on postnatal hippocampal neurogenesis in the mouse. Stem Cells. 2012;30(7):1532-43. doi: 10.1002/stem.1124 .
16. Mallet C, Barriere DA, Ermund A, Jonsson BA, Eschalier A, Zygmunt PM, et al. TRPV1 in brain is involved in acetaminophen-induced antinociception. PLoS One. 2010. doi: 10.1371/journal.pone.0012748 .
17. Starowicz K, Maione S, Cristino L, Palazzo E, Marabese I, Rossi F, et al. Tonic endovanilloid facilitation of glutamate release in brainstem descending antinociceptive pathways. J Neurosci. 2007;27(50):13739-49. doi: 10.1523/JNEUROSCI.3258-07.2007 .
18. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V, et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature. 1999;400(6743):452-7. doi: 10.1038/22761 .
19. Piomelli D, Sasso O. Peripheral gating of pain signals by endogenous lipid mediators. Nat Neurosci. 2014;17(2):164-74. doi: 10.1038/nn.3612 .
20. Glaser ST, Kaczocha M, Deutsch DG. Anandamide transport: a critical review. Life Sci. 2005;77(14):1584-604. doi: 10.1016/j.lfs.2005.05.007 .
21. Bjorklund E, Blomqvist A, Hedlin J, Persson E, Fowler CJ. Involvement of fatty acid amide hydrolase and fatty acid binding protein 5 in the uptake of anandamide by cell lines with different levels of fatty acid amide hydrolase expression: a pharmacological study. PLoS One. 2014;9(7):e103479. doi: 10.1371/journal.pone.0103479 .
22. Owada Y, Yoshimoto T, Kondo H. Spatio-temporally differential expression of genes for three members of fatty acid binding proteins in developing and mature rat brains. J Chem Neuroanat. 1996;12(2):113-22. pii: S0891-0618(96)00192-5.
23. Pegorini S, Zani A, Braida D, Guerini-Rocco C, Sala M. Vanilloid VR1 receptor is involved in rimonabant-induced neuroprotection. Br J Pharmacol. 2006;147(5):552-9. doi: 10.1038/sj.bjp.0706656 .